Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOvoca Bio Regulatory News (OVB)

  • There is currently no data for OVB

Re: Placing

17 Jun 2005 16:35

Ovoca Resources PLC17 June 2005 OVOCA RESOURCES PLC Placing to Raise €1.69 million 17 June 2005 - The Board of Ovoca Resources plc ("Ovoca" or "the Company") is pleased toannounce the conditional placing of 16,900,000 new Ordinary Shares of nominalvalue €0.025 ("New Ordinary Shares") in the capital of the Company at €0.10 pershare, equating to 18% of the existing issued share capital of the Company andraising in aggregate €1.69 million before expenses ("the Placing"). For each twoplacing shares subscribed for and allotted, the Company will issue a warrantexercisable at any time before 25 June 2006 to subscribe for one Ordinary Shareat €0.13. The Company intends to use the proceeds of the Placing to facilitatethe development of its exploration assets in Russia, Sweden and Ireland. Completion of the Placing is conditional upon on shareholder approval andadmission of the New Ordinary Shares to trading on the Irish Enterprise Exchange("IEX"). A document giving notice of an extraordinary general meeting (the"EGM") was posted to shareholders on 31 May 2005. The EGM has been convened for10.00 a.m. on Friday, 24 June, 2005 and will be held at The Berkeley CourtHotel, Lansdowne Road, Ballsbridge, Dublin 4, Ireland. It is expected that,subject to prior satisfaction of its conditions, the Placing will complete on 24June 2005. Enquiries to: Barrie Oakes +44 (0)795 1139266 Chief Executive Ovoca Resources plc Roger Turner +44 (0)1273 495500 Chairman Ovoca Resources plc John O'Connor +353 (0)1 491 2944 Finance Director Ovoca Resources plc Fergal Meegan +353 (0)1 679 6363 Davy Corporate Finance Limited This announcement has been issued through the Companies Announcement Service of The Irish Stock Exchange This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
29th Jul 20227:00 amRNSCompletion of Enrollment in Phase II Study
30th Jun 20227:00 amRNSAnnual Financial Report
7th Mar 20229:00 amRNSStatement re Russian Business Operations
23rd Feb 20224:41 pmRNSSecond Price Monitoring Extn
23rd Feb 20224:36 pmRNSPrice Monitoring Extension
22nd Feb 20223:30 pmRNSRussian Marketing Authorisation for Orenetide
31st Jan 20227:00 amRNSBoard Changes and Update
30th Dec 20217:00 amRNSDirectorate Change
4th Nov 20213:53 pmRNSHolding(s) in Company
4th Nov 20213:50 pmRNSDirector/PDMR Shareholding
4th Nov 20213:46 pmRNSBoard Change
14th Sep 20217:00 amRNSInterim Results
29th Jul 20215:00 pmRNSResult of AGM
24th Jun 20217:00 amRNSAnnual Report and Notice of AGM
10th Mar 20217:00 amRNSMigration of Participating Securities
16th Feb 20212:00 pmRNSResult of EGM
29th Jan 20217:00 amRNSFirst Patient Enrolled in Phase II Study - BP-101
25th Jan 20213:30 pmRNSNotice of EGM
5th Jan 20217:00 amRNSRe-Filing of Marketing Authorisation Application
17th Dec 20202:45 pmRNSResult of AGM
27th Nov 20203:08 pmRNSNotice of AGM
9th Oct 20207:00 amRNSAppointment of Chief Business Officer
2nd Oct 202011:06 amRNSSecond Price Monitoring Extn
2nd Oct 202011:00 amRNSPrice Monitoring Extension
2nd Oct 20209:05 amRNSSecond Price Monitoring Extn
2nd Oct 20209:00 amRNSPrice Monitoring Extension
2nd Oct 20207:00 amRNSUpdate re Russian Marketing Authorisation
28th Sep 20207:00 amRNSDeath of a Director
21st Sep 20207:00 amRNSInterim Results
14th Aug 202011:05 amRNSSecond Price Monitoring Extn
14th Aug 202011:00 amRNSPrice Monitoring Extension
26th Jun 20207:00 amRNSAnnual Report
14th Apr 20202:05 pmRNSSecond Price Monitoring Extn
14th Apr 20202:00 pmRNSPrice Monitoring Extension
24th Mar 20207:00 amRNSAcquisition of Remaining Minority Interest in IVIX
7th Nov 201912:45 pmRNSAttendance at Bio-Europe Conference
16th Sep 20197:00 amRNSInterim Results
12th Sep 20197:00 amRNSFiling of Marketing Authorisation Application
28th Aug 20197:00 amRNSDirectorate Change
8th Aug 20194:14 pmRNSResult of AGM
8th Aug 20199:05 amRNSSecond Price Monitoring Extn
8th Aug 20199:00 amRNSPrice Monitoring Extension
8th Aug 20197:00 amRNSAGM Statement
26th Jul 20197:00 amRNSDirectorate Change
25th Jul 20194:41 pmRNSSecond Price Monitoring Extn
25th Jul 20194:35 pmRNSPrice Monitoring Extension
28th Jun 20197:00 amRNSAnnual Report and Notice of AGM
23rd Apr 20197:00 amRNSUS and EU Clinical Development Plans
29th Mar 20197:00 amRNSDirector/PDMR Shareholding
27th Mar 20197:00 amRNSOperational Update & Additional Investment in IVIX

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.